Archives

by in
Entry Author Date Location
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
Pharmas, Others Bet $33M More on Aileron’s P53 Peptide Drug 10/29/14 Boston
Pappas, Chiesi Venture Fund Joins Ranks of Pharma & VC Partnerships 09/10/14 Raleigh Durham
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
Boston VC Firms, Pharmas Team up on $23.5M Series A For Navitor 06/19/14 Boston
With $22M, True North Points Toward Rare-Disease Clinical Trials 06/17/14 San Francisco
Seeking Tau: BMS Buys iPierian and Brain-Disease Program for $175M 04/29/14 San Francisco
Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs 04/09/14 Boston
San Diego’s RuiYi Raises $15M for Pipeline of Biologic Therapeutics 03/28/14 San Diego
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
ZappRx Gets $1M From Atlas, SR One to E-Prescribe Specialty Meds 01/30/14 Boston
ZappRx Obtains $1,000,000 Seed Round 01/30/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
Early Bird Ends Soon for Feb. 21 Healthcare Summit: Get Your Invite 01/23/14 Texas
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
Big Pharma Quartet Puts $30M Behind Aileron’s P53 Peptide Drug 11/18/13 Boston
Aileron Therapeutics Garners $30,000,000 Series E Funding Round 11/18/13 Boston
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
iPierian Receives $30,000,000 New Funding Round 09/04/13 San Francisco
True North Therapeutics Garners Series A Funding 09/04/13 San Francisco
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding 08/01/13 Boston
San Diego Life Sciences Roundup: Effector, Ignyta, and More 05/23/13 San Diego
Effector Therapeutics Raises $45M to Prove New Concept in Cancer 05/21/13 San Diego
eFFECTOR Therapeutics Lands $45,000,000 Series A Funding 05/21/13 San Diego
GlaxoSmithKline Shuts Down Sirtris, Five Years After $720M Buyout 03/12/13 Boston
Aileron Therapeutics Garners $12,000,000 Series D Financing 01/14/13 Boston
Page 1 of 5 next page »